Dr Bruce Burlington joins AZ board
July 30, 2010Research and Development, Sales and Marketing AstraZeneca, appointment, research and development, sales and marketing
AstraZeneca has appointed former FDA staffer Dr Bruce Burlington to its board as a non-executive director. Dr Burlington spent 17 …
JWT wins Pfizer account, denies it’s ‘Viagra 2’
July 30, 2010Medical Communications JWT, Pfizer, viagra
UK advertising agency JWT London has won an account from Pfizer, but played down media reports it had been appointed …
Sanofi’s blockbusters take a hit
July 29, 2010Sales and Marketing 2010 financials, Genzyme, Q2, Sanofi-Aventis
Generic pressures, European pricing pressures and the impact of the US health reforms combined to dent Sanofi-Aventis’s growth in the …
Contract research news in brief
July 29, 2010Research and Development CRO, LAB Research, Microsoft, PPD, PharmaNet, QPS, Selvita
Icon reports that new business wins rose healthily in the second quarter, plus there’s an alliance between PPD and Microsoft …
RSA expands European teams
July 29, 2010Business Services appointment, business services, rsa
Life sciences executive search and interim management firm RSA has made series of new appointments to some of the European …
Robert Thomson joins Photosound
July 29, 2010Medical Communications Photosound, appointment, medical communications
UK brand communcations agency Photosound has appointed Robert Thomson as head of digital product development. He has over 15 years’ …
Cardio3 BioSciences appoints Dr Atta Behfar
July 29, 2010Research and Development Cardio3, appointment, research and development
Belgium biotech company Cardio3 BioSciences has appointed Dr Atta Behfar as director for advanced research. He will spend a year …
UK lags behind Europe on innovative cancer drugs
July 29, 2010Sales and Marketing Cancer, market access
The UK has been ranked as one of the worst countries when it comes to uptake of new cancer drug …
Merck KGaA’s oral MS therapy gains US priority review
July 29, 2010Sales and Marketing Cladribine, MS, Merck KGaA
Merck’s cladribine has been granted a priority review status by the FDA in a move that could see it come …
Chiltern Announces its Financial Results for the Year Ended 31 March 2010
July 28, 2010Research and Development
Highlights• Revenues of £80.9 million, 9.8% ahead of the year ended March 2009. Of this, 1.5% is due to acquisitions, …
Digital Pharma: UK health clinic first for Pfizer
July 28, 2010Medical Communications Digital Pharma blog, Pfizer, digital patients, digital pharma med coms, disease awareness campaigns, sexual health
Men in the UK can now go online for confidential advice and information about any health problem through a unique …
Non-human sugars could compromise biologic drugs
July 28, 2010Manufacturing and Production biologicals, biologics, manufacturing
Many of the biologic drugs on the market today contain sugar molecule components that in some patients could undermine their …
NICE approves trio of cancer drugs
July 28, 2010Sales and Marketing Iressa, MabThera, NICE, Xeloda
NICE has given its final recommendation to a trio of drugs for the treatment of various cancers, which means the …
Lansley to create £50 million cancer drugs fund
July 28, 2010Sales and Marketing Cancer, NHS, government, market access
The UK government is setting up a multi-million pound fund dedicated to improving patient access to innovative new cancer drugs. …
Sir Paul Nurse to head up UKCMRI
July 28, 2010Research and Development UKCMRI, apppointment, research and development
The UK Centre for Medical Research and Innovation has appointed Sir Paul Nurse as its first director and chief executive. …
Not so new technologies
July 28, 2010Research and Development EDC, Les Rose, digital research
Let me take you back to a time that is now only dimly remembered. I don’t mean a time when …
Genzyme ponders Sanofi offer
July 27, 2010Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis
Sanofi-Aventis is understood to have approached the board of Genzyme with a takeover bid for the company. News agency Reuters …
NICE gets expanded role in quango cull
July 27, 2010MHRA, NHS, NICE, government
The bonfire of the quangos has begun in earnest in the health sector, with 18 so-called “arm’s length bodies” cut …
Bill would give FDA mandatory recall powers
July 27, 2010Manufacturing and Production FDA, manufacturing compliance, recalls
The chairman of the US congressional committee investigating the quality control problems at Johnson & Johnson, Edolphus Towns, has introduced …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
